Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Biomedicines
|
May 9, 2018
Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics
Graham McClorey, Subhashis Banerjee
Current Opinion in Pharmacology
|
August 17, 2015
An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies
Graham McClorey, Matthew J Wood
Plos Genetics
|
July 3, 2007
Modulating the expression of disease genes with RNA-based therapy
Matthew Wood, Haifang Yin, Graham McClorey
Current Opinion in Pharmacology
|
August 9, 2005
Splicing intervention for Duchenne muscular dystrophy
Graham McClorey, Susan Fletcher, Stephen Wilton
Genes
|
June 13, 2017
Splice-Switching Therapy for Spinal Muscular Atrophy
Katharina E Meijboom, Matthew J A Wood, Graham McClorey
Gene
|
December 14, 2011
Antisense oligonucleotide corrects splice abnormality in hereditary myopathy with lactic acidosis
Petter Schandl Sanaker, Marina Toompuu, Graham McClorey, et al.
The Journal of Gene Medicine
|
November 20, 2002
Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy
Christopher J Mann, Kaite Honeyman, Graham McClorey, et al.
Molecular Therapy. Nucleic Acids
|
January 25, 2013
Small RNA-Mediated Epigenetic Myostatin Silencing
Thomas C Roberts, Samir El Andaloussi, Kevin V Morris, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 8, 2007
Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript
Steve D Wilton, Abbie M Fall, Penny L Harding, et al.
Nucleic Acids Research
|
December 4, 2014
Bi-specific splice-switching PMO oligonucleotides conjugated via a single peptide active in a mouse model of Duchenne muscular dystrophy
Fazel Shabanpoor, Graham McClorey, Amer F Saleh, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Biomedicines
|
May 9, 2018
Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics
Graham McClorey, Subhashis Banerjee
Current Opinion in Pharmacology
|
August 17, 2015
An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies
Graham McClorey, Matthew J Wood
Plos Genetics
|
July 3, 2007
Modulating the expression of disease genes with RNA-based therapy
Matthew Wood, Haifang Yin, Graham McClorey
Current Opinion in Pharmacology
|
August 9, 2005
Splicing intervention for Duchenne muscular dystrophy
Graham McClorey, Susan Fletcher, Stephen Wilton
Genes
|
June 13, 2017
Splice-Switching Therapy for Spinal Muscular Atrophy
Katharina E Meijboom, Matthew J A Wood, Graham McClorey
Gene
|
December 14, 2011
Antisense oligonucleotide corrects splice abnormality in hereditary myopathy with lactic acidosis
Petter Schandl Sanaker, Marina Toompuu, Graham McClorey, et al.
The Journal of Gene Medicine
|
November 20, 2002
Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy
Christopher J Mann, Kaite Honeyman, Graham McClorey, et al.
Molecular Therapy. Nucleic Acids
|
January 25, 2013
Small RNA-Mediated Epigenetic Myostatin Silencing
Thomas C Roberts, Samir El Andaloussi, Kevin V Morris, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 8, 2007
Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript
Steve D Wilton, Abbie M Fall, Penny L Harding, et al.
Nucleic Acids Research
|
December 4, 2014
Bi-specific splice-switching PMO oligonucleotides conjugated via a single peptide active in a mouse model of Duchenne muscular dystrophy
Fazel Shabanpoor, Graham McClorey, Amer F Saleh, et al.
Page
of 4